Cargando…

Preoperative immune landscape predisposes adverse outcomes in hepatocellular carcinoma patients with liver transplantation

Immune class in hepatocellular carcinoma (HCC) has been shown to possess immunogenic power; however, how preestablished immune landscapes in premalignant and early HCC stages impact the clinical outcomes of HCC patients remains unexplored. We sequenced bulk transcriptomes for 62 malignant tumor samp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Sang-Ho, Choi, Seo-Won, Nam, Suk Woo, Lee, Kyoung Bun, Nam, Jin-Wu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997876/ https://www.ncbi.nlm.nih.gov/pubmed/33772139 http://dx.doi.org/10.1038/s41698-021-00167-2

Ejemplares similares

Prognosis of Hepatocellular Carcinoma after Liver Transplantation: Comparative Analysis with Partial Hepatectomy
por: Lee, Kyuho, et al.
Publicado: (2017)

False Positive Diagnosis of Hepatocellular Carcinoma in Liver Resection Patients
por: Lee, Hongeun, et al.
Publicado: (2017)

Peri-Transplant Change in AFP Level: a Useful Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation
por: Yoo, Tae, et al.
Publicado: (2016)

Preoperative Magnetic Resonance Image and Computerized Tomography Findings Predictive of Facial Nerve Invasion in Patients with Parotid Cancer without Preoperative Facial Weakness—A Retrospective Observational Study
por: Cho, Won Ki, et al.
Publicado: (2022)

T-cell immune regulator 1 enhances metastasis in hepatocellular carcinoma
por: Yang, Hee Doo, et al.
Publicado: (2018)

Preoperative blood neutrophil count predicts survival in hepatocellular carcinoma patients with living donor liver transplantation
por: Hong, Young Mi, et al.
Publicado: (2020)

Liver transplantation for advanced hepatocellular carcinoma
por: Lee, Hae Won, et al.
Publicado: (2016)

Tailored Prediction Model of Survival after Liver Transplantation for Hepatocellular Carcinoma
por: Jamtani, Indah, et al.
Publicado: (2021)

Optimal Tailored Screening Protocol after Living Donor Liver Transplantation for Hepatocellular Carcinoma
por: Park, Min-Su, et al.
Publicado: (2014)

The impact of Model for End-Stage Liver Disease score on deceased donor liver transplant outcomes in low volume liver transplantation center: a retrospective and single-center study
por: Lee, Doo-Ho, et al.
Publicado: (2021)

Risk Factors for the Adverse Events after Conversion from Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplantation Patients
por: Suh, Suk-Won, et al.
Publicado: (2016)

Preoperative Selective Desensitization of Live Donor Liver Transplant Recipients Considering the Degree of T Lymphocyte Cross-Match Titer, Model for End-Stage Liver Disease Score, and Graft Liver Volume
por: Hong, Geun, et al.
Publicado: (2014)

Alteration of MRP2 expression and the graft outcome after liver transplantation
por: Yi, Nam-Joon, et al.
Publicado: (2018)

Recurrence in patients with totally necrotic nodules of hepatocellular carcinoma after liver transplantation: “totally” an inaccurate description
por: Kim, Jiyoung, et al.
Publicado: (2023)

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation
por: Lee, Ju-Yeun, et al.
Publicado: (2014)

Fatigue and related factors after liver transplantation
por: Hong, Kwangpyo, et al.
Publicado: (2015)

Living donor liver transplantation should be cautiously considered as initial treatment in recurrent hepatocellular carcinoma within the Milan criteria after curative liver resection
por: Kim, Jong Man, et al.
Publicado: (2020)

Outcomes of Living Donor Liver Transplantation in Patients With a History of Ruptured Hepatocellular Carcinoma
por: Lee, Hwi Yeol, et al.
Publicado: (2021)

Real-Life Experience of mTOR Inhibitors in Liver Transplant Recipients in a Region Where Living Donation Is Predominant
por: Sung, Pil Soo, et al.
Publicado: (2021)

Ventilator support in the pretransplant period predisposes early graft failure after deceased donor liver transplantation
por: Lee, Nuri, et al.
Publicado: (2023)

Outcomes of Split Liver Transplantation vs Living Donor Liver Transplantation in Pediatric Patients: A 5-Year Follow-Up Study in Korea
por: Yoon, Kyung Chul, et al.
Publicado: (2022)

Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
por: Lee, Soon Kyu, et al.
Publicado: (2020)

Rare Pathogenic Variants Predispose to Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Pelusi, Serena, et al.
Publicado: (2019)

Hemojuvelin deficiency promotes liver mitochondrial dysfunction and predisposes mice to hepatocellular carcinoma
por: Allameh, Abdolamir, et al.
Publicado: (2022)

Impact of the preoperative skeletal muscle index on early remnant liver regeneration in living donors after liver transplantation
por: Lee, Sunyoung, et al.
Publicado: (2022)

Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy
por: Li, Shuang-Xi, et al.
Publicado: (2016)

Diagnostic Role of Tumor Markers for Hepatocellular Carcinoma in Liver Transplantation Candidates: An Analysis Using the Korean Organ Transplantation Registry Database
por: Kang, Woo-Hyoung, et al.
Publicado: (2022)

Gastrokine 1 Expression in the Human Gastric Mucosa Is Closely Associated with the Degree of Gastritis and DNA Methylation
por: Choi, Won Suk, et al.
Publicado: (2013)

Nuclear Expression of Hepatitis B Virus X Protein Is Associated with Recurrence of Early-Stage Hepatocellular Carcinomas: Role of Viral Protein in Tumor Recurrence
por: Jin, Jing, et al.
Publicado: (2016)

The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas
por: Lee, KyuHo, et al.
Publicado: (2017)

Gastrokine 1 induces senescence and apoptosis through regulating telomere length in gastric cancer
por: Yoon, Jung Hwan, et al.
Publicado: (2014)

Evolving Landscape in Liver Transplantation for Hepatocellular Carcinoma: From Stage Migration to Immunotherapy Revolution
por: Cesario, Silvia, et al.
Publicado: (2023)

RNF43/ZNRF3 loss predisposes to hepatocellular-carcinoma by impairing liver regeneration and altering the liver lipid metabolic ground-state
por: Belenguer, Germán, et al.
Publicado: (2022)

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria
por: Cho, Yuri, et al.
Publicado: (2017)

Predictive Model for the Assessment of Preoperative Frailty Risk in the Elderly
por: Lee, Sang-Wook, et al.
Publicado: (2021)

Statin Use is Associated with Decreased Hepatocellular Carcinoma Recurrence in Liver Transplant Patients
por: Cho, Yongin, et al.
Publicado: (2019)

Early acute kidney injury after liver transplantation: Predisposing factors and clinical implications
por: Rahman, Suehana, et al.
Publicado: (2017)

Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation
por: Chen, Zhitao, et al.
Publicado: (2020)

Liver transplantation for combined hepatocellular carcinoma and cholangiocarcinoma: A multicenter study
por: Kim, Jongman, et al.
Publicado: (2023)

Long Term Outcomes of Pediatric Liver Transplantation According to Age
por: Byun, Jeik, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d64u4hklidvhujn50ohahl9a4j